High seroconversion rate to trivalent influenza vaccine during ustekinumab treatment in Crohn's disease: results from a prospective cohort study

Rogier Goetgebuer  1     Laura Doornekamp  1     Gwenny M. Fuhler  1     Maikel P. Peppelenbosch  1     C. Janneke van der Woude  2     Eric C.M. van Gorp     Annemarie C. De Vries    
1 Erasmus MC, University Medical Center Rotterdam,Rotterdam,Netherlands
2 Erasmus MC, University Medical Center Rotterdam,Rotte

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing